Qiagen N.V.
QGEN · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -1.51 | -1.41 | -1.52 | 0.04 |
| FCF Yield | 5.38% | 3.12% | 5.10% | 3.49% |
| EV / EBITDA | 27.62 | 15.07 | 15.71 | 15.04 |
| Quality | ||||
| ROIC | 1.29% | 5.77% | 7.66% | 9.38% |
| Gross Margin | 48.90% | 62.77% | 64.65% | 64.43% |
| Cash Conversion Ratio | 8.06 | 1.35 | 1.69 | 1.25 |
| Growth | ||||
| Revenue 3-Year CAGR | -2.61% | -4.43% | 4.62% | 13,106,822.90% |
| Free Cash Flow Growth | 70.70% | -47.58% | 30.86% | 129.99% |
| Safety | ||||
| Net Debt / EBITDA | 2.04 | 1.25 | 1.48 | 1.21 |
| Interest Coverage | 2.23 | 7.68 | 9.11 | 11.57 |
| Efficiency | ||||
| Inventory Turnover | 3.62 | 1.84 | 2.11 | 2.45 |
| Cash Conversion Cycle | 155.45 | 252.53 | 198.98 | 179.28 |